Suppr超能文献

器官型培养中的人肺癌结节:未发现干扰素的抗增殖作用与2',5'-寡腺苷酸合成酶诱导之间存在相关性的证据。

Human lung cancer nodules in organotypic culture: no evidence of correlation between the antiproliferative effects of interferons and the induction of 2',5'-oligoadenylate synthetase.

作者信息

Martyré M C, Beaupain R, Falcoff E

机构信息

U 196 INSERM, Institut Curie, Paris, France.

出版信息

Tumour Biol. 1988;9(5):263-9. doi: 10.1159/000217570.

Abstract

Alveolar II pulmonary tumor cells (A549), maintained in continuous tridimensional organotypic culture, were used in an attempt to investigate whether there could be a relationship of the 2',5'-oligoadenylate (2,5A) synthetase pathway to the antiproliferative activity of interferons (IFNs) in this particular tumor cell model. IFN-alpha 2, -beta and -gamma were used separately and in combinations. IFN-alpha 2 and -gamma demonstrated an inhibitory effect on the nodule growth, whereas IFN-beta did not. Moreover, combinations of IFN-alpha 2 and -gamma resulted in a significant synergistic antiproliferative activity; IFN-beta only potentiated slightly the effect of IFN-gamma. All three IFNs induced an increase in the 2,5A synthetase activity, indicating a discrepancy with the pattern of anticellular activity. Furthermore, whereas the combination of IFN-alpha 2 and -gamma resulted in a synergistic antiproliferative effect, no synergism was observed in the induction of the enzyme. These results show that there is a lack of correlation between the sensitivity or the resistance to IFNs of A549 tumor nodules and the induction of the 2,5A synthetase activity.

摘要

维持在连续三维器官型培养中的肺泡II型肺肿瘤细胞(A549),被用于尝试研究在这个特定的肿瘤细胞模型中,2',5'-寡腺苷酸(2,5A)合成酶途径与干扰素(IFN)的抗增殖活性之间是否存在关联。单独及联合使用了IFN-α2、-β和-γ。IFN-α2和-γ对结节生长表现出抑制作用,而IFN-β则没有。此外,IFN-α2和-γ的联合导致了显著的协同抗增殖活性;IFN-β仅略微增强了IFN-γ的作用。所有三种IFN均诱导2,5A合成酶活性增加,这表明与抗细胞活性模式存在差异。此外,虽然IFN-α2和-γ的联合产生了协同抗增殖作用,但在该酶的诱导中未观察到协同作用。这些结果表明,A549肿瘤结节对IFN的敏感性或抗性与2,5A合成酶活性的诱导之间缺乏相关性。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验